Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of GZMB mRNA | affects expression | 21346803
|
C430898 |
AGN 194204 |
AGN 194204 results in increased expression of GZMB mRNA | increases expression | 16339527
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GZMB mRNA | affects expression | 16483693
|
D001374 |
Azacitidine |
Azacitidine inhibits the reaction [IL2 protein results in increased secretion of GZMB protein] | decreases reaction|increases secretion | 19394699
|
D003436 |
Croton Oil |
Croton Oil results in increased expression of GZMB mRNA | increases expression | 18652873
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in increased expression of GZMB mRNA | increases expression | 15331540
|
D004041 |
Dietary Fats |
Dietary Fats affects the expression of GZMB mRNA | affects expression | 18457598
|
D004137 |
Dinitrochlorobenzene |
Dinitrochlorobenzene results in increased expression of GZMB mRNA | increases expression | 18652873
|
D000431 |
Ethanol |
Ethanol inhibits the reaction [IL2 protein results in increased expression of GZMB mRNA] | decreases reaction|increases expression | 12700414
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of GZMB mRNA | decreases expression | 20145137
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of GZMB protein | decreases expression | 20145137
|
C070081 |
fulvestrant |
[fulvestrant results in increased expression of TGFB1 protein] which results in increased expression of GZMB mRNA | increases expression | 20145137
|
D010081 |
Oxazolone |
Oxazolone results in decreased expression of GZMB mRNA | decreases expression | 11379042
|
D010081 |
Oxazolone |
Oxazolone results in increased expression of GZMB mRNA | increases expression | 18652873
|
C008776 |
pelargonic acid |
pelargonic acid results in decreased expression of GZMB mRNA | decreases expression | 11379042
|
C008776 |
pelargonic acid |
pelargonic acid results in increased expression of GZMB mRNA | increases expression | 18652873
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GZMB mRNA | decreases expression | 17426115
|
C025299 |
polyphenols |
polyphenols results in decreased expression of GZMB mRNA | decreases expression | 16293270
|
D011374 |
Progesterone |
Progesterone affects the expression of GZMB mRNA | affects expression | 17251523
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid inhibits the reaction [IL2 protein results in increased expression of GZMB mRNA] | decreases reaction|increases expression | 12700414
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of GZMB mRNA | decreases expression | 20145137
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of GZMB protein | decreases expression | 20145137
|
D013629 |
Tamoxifen |
[Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of GZMB mRNA | increases expression | 20145137
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in decreased expression of GZMB mRNA | decreases expression | 11379042
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in increased expression of GZMB mRNA | increases expression | 18652873
|
D014107 |
Tosyllysine Chloromethyl Ketone |
Tosyllysine Chloromethyl Ketone inhibits the reaction [IL2 protein results in increased expression of GZMB mRNA] | decreases reaction|increases expression | 12700414
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of GZMB protein | decreases expression | 17107666
|
C088658 |
zoledronic acid |
IL2 protein affects the reaction [zoledronic acid affects the expression of GZMB mRNA] | affects expression|affects reaction | 19446661
|
C088658 |
zoledronic acid |
zoledronic acid affects the expression of GZMB mRNA | affects expression | 19446661
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
8.51 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
8.51 | 18926900 17676605 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
10.11 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
10.11 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.36 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.01 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.37 | 20200999 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.37 | 16434500 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.21 | 15451040 15451039 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.71 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.92 | 11141031 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
9.96 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.96 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.01 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
5.16 | 15590890 11742282 6091946 8156442 10934080 12762349 3040596 16792590 18394133 12585506 17015710 16210060 170078 15855793 7684630 10797510 15590891 12684321 19187332 6091945 11077013 11467998 20032816 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.16 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.74 | 11514358 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18762240 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.64 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.64 | 16206674 16197459 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.85 | 17312309 19442620 16778634 11697798 15867366 16121404 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.60 | 18404659 18496637 15845617 16769263 11869084 8053405 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.23 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.15 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 19446661 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
4.66 | 17388661 11325840 18234424 15136595 17020986 16978400 18323546 12006526 15093573 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.66 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
4.66 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.66 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.66 | 19189212 17261762 19221464 18984771 19115204 16818667 18351453 20390343 18815881 17049068 17893378 18425577 19011961 19289846 19084267 19244106 11161223 17440819 20544844 20005174 19155303 15565566 19189210 19410462 20135344 16273361 18855134 18821012 19142967 19066611 18629630 21138602 16202921 19288272 17242785 19200415 21152245 19487384 18997820 19103187 15668708 16873071 19059307 20859285 20065188 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
4.66 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.66 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
4.66 | 16096432 18695136 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
4.45 | 8156442 15590891 12507178 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002056 |
Burns |
|
Ethanol |
4.54 | 16374292 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.40 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
6.50 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
6.50 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.50 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.50 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.78 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.50 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.95 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
6.95 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.26 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.52 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.38 | 19332462 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.40 | 14694615 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.40 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.74 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.53 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
6.01 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.01 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D003093 |
Colitis, Ulcerative |
|
Dinitrochlorobenzene |
3.82 | 19159591 17373747 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.66 | 16293270 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.72 | 19934284 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.06 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.81 | 15451040 19302082 10194807 15451039 11873399 11198716 15513904 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.81 | 10589399 9211117 16925845 9224671 9125849 14991402 17551590 8800419 9664655 9142499 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.88 | 18710439 18372110 18483878 18433785 18295254 12913760 16989017 18093676 16651033 10498854 16413132 16614059 12388444 15276878 17010015 15643279 17979934 12161096 11948286 10700343 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.25 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dinitrochlorobenzene |
7.45 | 15491423 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
7.45 | 12956900 15491423 18759878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
Oxazolone |
9.83 | 12811023 15944321 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
9.83 | 17010967 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.97 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.19 | 18772604 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.38 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.38 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
6.32 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
6.32 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.32 | 19370779 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.37 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.38 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.36 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.81 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.81 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.20 | 20544844 16202921 17893378 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.20 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.67 | 16134523 |
MESH:D004751 |
Enteritis |
|
Croton Oil |
6.24 | 8982514 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
9.09 | 11006010 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
9.09 | 8156442 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.73 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.49 | 16938888 9664655 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
5.64 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
17.96 | 19004024 19551842 18296743 17967931 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
17.96 | 18620774 19236843 16409862 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.96 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.96 | 19224547 14986274 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.56 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.17 | 16709447 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.72 | 16234978 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.19 | 15451040 16946407 10194807 15513904 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.07 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.47 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.47 | 17994277 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.59 | 15046732 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.93 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.40 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.93 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.11 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.84 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.47 | 20558911 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.18 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.43 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.89 | 16221962 19176532 19772884 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.69 | 17606976 16135485 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
12.77 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
12.77 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
12.77 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.94 | 19622757 18089816 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.49 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.51 | 21332399 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.50 | 10880147 11019492 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.09 | 12669777 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.23 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.29 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
7.09 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
7.09 | 11514358 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.55 | 20412841 |
MESH:D007249 |
Inflammation |
|
polyphenols |
11.55 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
11.55 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.55 | 19457130 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
5.45 | 18473937 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.01 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.01 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.99 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.99 | 17551590 15992940 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.95 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
4.10 | 15451040 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
10.36 | 19148494 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
10.36 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.36 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.45 | 17802794 18172266 17658394 17008537 17296974 18587576 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.67 | 18089816 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.00 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
9.45 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.45 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
4.13 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.13 | 17596541 16294345 19850784 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.09 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.08 | 17712046 16823087 17339181 17649720 17107899 16891316 16331271 17294898 12679006 19035177 16140955 19642359 17361223 19075265 16766008 9834237 17301526 16788101 19225113 17506722 19029980 16935935 17217047 17368321 15748426 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.86 | 10052129 11830472 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
8.05 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
8.05 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.08 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.64 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.64 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.99 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
6.62 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.62 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
6.62 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.62 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.62 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.76 | 16698588 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.54 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.30 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.30 | 16684651 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
4.88 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
2.76 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.76 | 18625569 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.76 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.49 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.08 | 11911406 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.65 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.72 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.72 | 11731420 19196722 14580682 16827153 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
9.72 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.44 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
Dinitrochlorobenzene |
5.14 | 17334785 12202904 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.14 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.14 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.07 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.69 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
4.08 | 15451040 18411066 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.71 | 16675582 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.98 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
7.70 | 19549372 18443271 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
7.70 | 16996129 18089719 19621390 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.40 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
7.50 | 18720364 17611569 19805378 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.50 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.10 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.86 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.98 | 19393235 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
5.98 | 15867366 19139120 17312309 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.48 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.01 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.01 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.01 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
4.62 | 1670384 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.89 | 19189210 19196722 19200415 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.67 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
2.98 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.58 | 8761367 15176712 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.78 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.22 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.34 | 11836018 20132043 21332399 19632207 17217161 18457598 16723640 20518802 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.34 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
9.28 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
9.28 | 11077013 18394133 6091946 12585506 8156442 3040596 6091945 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.60 | 16517039 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.26 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
3.97 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.80 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.80 | 16936753 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
10.97 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
Tretinoin |
10.97 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
10.97 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
8.55 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
8.55 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.55 | 15976015 |
MESH:D010212 |
Papilloma |
|
Croton Oil |
5.68 | 16517061 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.74 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
1.91 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.91 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
1.91 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
1.91 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.91 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
1.91 | 12438248 19103299 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
5.52 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.24 | 16636934 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
4.89 | 16129981 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.36 | 16940033 20219652 7692837 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
5.01 | 18447907 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.99 | 16116481 16283617 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
4.48 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
5.17 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
5.41 | 19075512 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.82 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
4.83 | 16121404 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.72 | 16636934 |
MESH:D012640 |
Seizures |
|
Ethanol |
3.10 | 9754883 |
MESH:D012878 |
Skin Neoplasms |
|
Croton Oil |
6.39 | 16517061 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.39 | 16467112 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
5.41 | 19075512 19050374 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.19 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.40 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.51 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.51 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.59 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.59 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.43 | 11906479 9562338 16755016 9211565 17918041 17189318 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.16 | 9754883 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.95 | 12837982 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.15 | 17997062 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.94 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.69 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.21 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.21 | 8653321 16712894 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.58 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.64 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |